Business Description
Lumos Diagnostics Holdings Ltd
ISIN : AU0000157091
Share Class Description:
LDXHF: Ordinary SharesDescription
Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. It also directly develops, manufactures and commercializes proprietary, Lumos-branded POC tests that target infectious and inflammatory diseases. It generates maximum revenue from the commercial services and solutions relating to POC diagnostic tests.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.16 | |||||
Equity-to-Asset | 0.4 | |||||
Debt-to-Equity | 0.92 | |||||
Debt-to-EBITDA | -1.72 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 74.98 | |||||
9-Day RSI | 46.02 | |||||
14-Day RSI | 35.02 | |||||
6-1 Month Momentum % | -16.86 | |||||
12-1 Month Momentum % | -64.25 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.69 | |||||
Quick Ratio | 0.48 | |||||
Cash Ratio | 0.22 | |||||
Days Inventory | 147.26 | |||||
Days Sales Outstanding | 94.27 | |||||
Days Payable | 267.89 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 59.72 | |||||
Operating Margin % | -113.49 | |||||
Net Margin % | -107.49 | |||||
FCF Margin % | -105.78 | |||||
ROE % | -89.57 | |||||
ROA % | -36.11 | |||||
ROIC % | -38.35 | |||||
ROC (Joel Greenblatt) % | -96.5 | |||||
ROCE % | -47.89 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.78 | |||||
PB Ratio | 1.07 | |||||
EV-to-EBIT | -2.19 | |||||
EV-to-EBITDA | -3.47 | |||||
EV-to-Revenue | 2.1 | |||||
EV-to-FCF | -1.98 | |||||
Earnings Yield (Greenblatt) % | -45.66 | |||||
FCF Yield % | -86.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:LDXHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lumos Diagnostics Holdings Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 8.214 | ||
EPS (TTM) ($) | -0.021 | ||
Beta | 0 | ||
Volatility % | 780.02 | ||
14-Day RSI | 35.02 | ||
14-Day ATR ($) | 0.000447 | ||
20-Day SMA ($) | 0.0291 | ||
12-1 Month Momentum % | -64.25 | ||
52-Week Range ($) | 0.0139 - 0.095 | ||
Shares Outstanding (Mil) | 481.31 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Lumos Diagnostics Holdings Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Lumos Diagnostics Holdings Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Lumos Diagnostics Holdings Ltd Frequently Asked Questions
What is Lumos Diagnostics Holdings Ltd(LDXHF)'s stock price today?
The current price of LDXHF is $0.03. The 52 week high of LDXHF is $0.10 and 52 week low is $0.01.
When is next earnings date of Lumos Diagnostics Holdings Ltd(LDXHF)?
The next earnings date of Lumos Diagnostics Holdings Ltd(LDXHF) is 2024-07-19 Est..
Does Lumos Diagnostics Holdings Ltd(LDXHF) pay dividends? If so, how much?
Lumos Diagnostics Holdings Ltd(LDXHF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |